Blog
Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
CVS Health’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported
Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release
Tempus AI TEM is entering a phase of strong operating momentum, backed by significant acceleration in both revenues and gross profit. This trend became particularly clear in the company’s last two
Will Energy Transfer's Wide Pipeline Network Power Long-Term Growth?
Energy Transfer LP ET is strategically positioned to benefit from its vast and diversified midstream infrastructure network, which spans nearly 140,000 miles of pipelines across North America. This
Here's Why Investors Should Avoid ZTO Express Stock Now
ZTO Express Cayman Inc. ZTO is grappling with challenges ranging from rising operating expenses and deteriorating liquidity position, which are adversely affecting its bottom line and making it an
Petrobras Bets Big on Rio's Refining Commitment With Major Projects
Petróleo Brasileiro S.A. - Petrobras PBR is making bold strides in revitalizing Brazil’s downstream sector. It announced a sweeping $33 billion reais ($6 billion) investment plan centered in Rio de
Will Semiconductor and Biotech Drive EMCOR's Bookings?
EMCOR Group, Inc.’s EME prospects are notably benefiting from several initiatives that the United States government has undertaken to foster public infrastructure. Initiatives like the CHIPS Act and
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer
AstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a bladder cancer indication in the European Union (EU).
The regulatory body
If You Invested $1000 in Royal Caribbean a Decade Ago, This is How Much It'd Be Worth Now
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
If You Invested $1000 in SkyWest a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
If You Invested $1000 in Heico Corporation a Decade Ago, This is How Much It'd Be Worth Now
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across
Here's How Much a $1000 Investment in Fiserv Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
How Strong is DraftKings' Path to Free Cash Flow in 2025?
DraftKings Inc. DKNG is transitioning from a high-growth story to a disciplined, cash-generating business, and 2025 could mark a critical turning point. With a reaffirmed free cash flow (FCF) target
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest way to judge a
3 Great Mutual Fund Picks for Your Retirement
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
How can you tell a good mutual
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
How can
Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment
While Harmony Biosciences HRMY may not be a typical cannabis stock involved in cultivation, processing, or sales of marijuana products, it is among the few companies evaluating an investigational
Macau's Recovery Accelerates: Will Melco's Top Line Keep Up?
Macau’s recovery from pandemic-era lows is gaining steam and Melco Resorts & Entertainment MLCO appears to be riding that wave.
Melco delivered a strong performance in the first quarter, beating
How Flotek's Well Chemistry Enhances Drilling Performance
In the world of building oil and gas wells, special chemicals are more than just ingredients; they are key tools for better results. Flotek Industries’ FTK customized drilling and cementing
PRM Unveils State-of-the-Art Fire Retardant Production Facility
Perimeter Solutions PRM has inaugurated a state-of-the-art PHOS-CHEK facility at McClellan Park in Sacramento, CA, reportedly one of the world’s leading fire retardant production facilities
Is AngloGold Ashanti on Track to Meet 2025 Production Targets?
AngloGold Ashanti PLC AU has kicked off 2025 on a high note, posting its best first-quarter gold production since 2020 and setting an optimistic tone for the rest of the year. Driven by the
Buy 2 AI-Powered Technology Services Stocks to Tap Lucrative Upside
The technology services industry is mature, with demand for services in good shape. Revenues, income and cash flows are anticipated to gradually returned to the pre-pandemic levels, enabling most
Is WHIAX a Strong Bond Fund Right Now?
Any investors hoping to find a High Yield - Bonds fund might consider looking past Macquarie High Income A (WHIAX). WHIAX has a Zacks Mutual Fund Rank of 5 (Strong Sell), which is based on various
Is DLSNX a Strong Bond Fund Right Now?
On the lookout for a Mortgage - Bonds: Misc fund? Starting with DoubleLine Low Duration Bond N (DLSNX) is one possibility. DLSNX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based
Is ECMMX a Strong Bond Fund Right Now?
On the lookout for a Muni - Bonds fund? Starting with Eaton Vance MA Municipals C (ECMMX) should not be a possibility at this time. ECMMX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is



